These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1970451)

  • 1. Tardive dyskinesia in psychiatric patients with substance use disorders.
    Olivera AA; Kiefer MW; Manley NK
    Am J Drug Alcohol Abuse; 1990; 16(1-2):57-66. PubMed ID: 1970451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased tardive dyskinesia in alcohol-abusing schizophrenic patients.
    Dixon L; Weiden PJ; Haas G; Sweeney J; Frances AJ
    Compr Psychiatry; 1992; 33(2):121-2. PubMed ID: 1347498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in tardive dyskinesia.
    Wegner JT; Kane JM; Weinhold P; Woerner M; Kinon B; Lieberman J
    Psychiatry Res; 1985 Dec; 16(4):331-7. PubMed ID: 2868476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients.
    Bailey LG; Maxwell S; Brandabur MM
    Psychopharmacol Bull; 1997; 33(1):177-81. PubMed ID: 9133772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of tardive dyskinesia among three ethnic groups of chronic psychiatric patients.
    Sramek J; Roy S; Ahrens T; Pinanong P; Cutler NR; Pi E
    Hosp Community Psychiatry; 1991 Jun; 42(6):590-2. PubMed ID: 1677921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia in affective disorders.
    Kane JM
    J Clin Psychiatry; 1999; 60 Suppl 5():43-7; discussion 48-9. PubMed ID: 10192407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients.
    Jeste DV; Lacro JP; Palmer B; Rockwell E; Harris MJ; Caligiuri MP
    Am J Psychiatry; 1999 Feb; 156(2):309-11. PubMed ID: 9989570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical forms of severe tardive dyskinesia.
    Gardos G; Cole JO; Salomon M; Schniebolk S
    Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does clozapine cause tardive dyskinesia?
    Kane JM; Woerner MG; Pollack S; Safferman AZ; Lieberman JA
    J Clin Psychiatry; 1993 Sep; 54(9):327-30. PubMed ID: 8104929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia and antipsychotics: a 5-year longitudinal study of frequency, correlates and course.
    Eberhard J; Lindström E; Levander S
    Int Clin Psychopharmacol; 2006 Jan; 21(1):35-42. PubMed ID: 16317315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current cannabis use and tardive dyskinesia.
    Zaretsky A; Rector NA; Seeman MV; Fornazzari X
    Schizophr Res; 1993 Dec; 11(1):3-8. PubMed ID: 7905284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-right-handedness and maleness correlate with tardive dyskinesia among patients taking neuroleptics.
    Joseph AB
    Acta Psychiatr Scand; 1990 Jun; 81(6):530-3. PubMed ID: 1974104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
    Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
    J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
    [No Abstract]   [Full Text] [Related]  

  • 18. Affective disorders and tardive dyskinesia.
    Casey DE
    Encephale; 1988 Sep; 14 Spec No():221-6. PubMed ID: 2905650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.
    Morgenstern H; Glazer WM
    Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
    Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N
    J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.